CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 64 enrolled
Drug / intervention
Tranexamic Acid (Cyklokapron)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02053363
NCT02053363Phase 3Completed
CompareCT.gov

Low Versus High Dose Tranexamic Acid in Adult Spinal Deformity Surgery: A Randomized, Blinded, Controlled Trial

Washington University School of Medicine·interventional·Posted Feb 3, 2014·Updated Jun 8, 2022

In Brief

A Phase 3 clinical trial evaluating Tranexamic Acid (Cyklokapron) for Adult Spinal Deformity. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate two dosing protocols for tranexamic acid (TXA), an anti-fibrinolytic used to decrease blood loss in adult patients undergoing complex, reconstructive spinal fusion surgeries.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdult Spinal Deformity
CountriesUnited States
CollaboratorsAOSpine North America

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 3, 2014
Enrollment StartMar 1, 2014
Primary CompletionJun 26, 2020
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 12.4 years ago

Interventions

Tranexamic Acid (Cyklokapron)drug